Anesthesia and perioperative pain management during cardiac electronic device implantation

Marina Biocic1, Dijana Vidosevic2, Matija Boric1,3

  • 1Laboratory for Pain Research, University of Split School of Medicine.

Insights

Patients undergoing cardiac electronic device (CED) implantation often experience severe pain during and after the procedure. Current perioperative pain management is insufficient, indicating a need for improved sedation and analgesia strategies.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Pain Management

Background:

  • Pain associated with cardiac electronic device (CED) implantation and its management are understudied.
  • Existing perioperative pain management practices for CED implantation require further investigation.

Purpose of the Study:

  • To analyze perioperative pain management strategies used during CED implantation.
  • To assess the intensity and location of pain experienced by patients undergoing CED implantation.
  • To compare current practices with established guidelines for acute perioperative pain management.

Main Methods:

  • A combined retrospective (321 patients) and prospective (51 patients) study design.
  • Data collected from a tertiary hospital, University Hospital Split, Croatia.
  • Pain intensity measured using a numerical rating scale (NRS) from 0 to 10.

Main Results:

  • Only a quarter of patients received pre-operative analgesia or sedation; all received local lidocaine anesthesia.
  • Post-operatively, 31% of patients received pain medication or sedation.
  • Severe pain (NRS >5) was reported during and up to 24 hours after implantation, with common locations including the surgical site, shoulder, and chest.
  • Adherence to acute perioperative pain management guidelines was insufficient.

Conclusions:

  • Patients undergoing CED implantation frequently experience severe pain.
  • Current perioperative pain management is suboptimal, necessitating increased sedation and analgesia.
  • Development of specific guidelines for anesthesia and pain management during CED implantation is recommended.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
405
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
907
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
897
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
830
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
885